The Role of ALDH2 in Sepsis and the To-Be-Discovered Mechanisms.

Abstract

Sepsis, defined as life-threatening tissue damage and organ dysfunction caused by a dysregulated host response to infection, is a critical disease which imposes global health burden. Sepsis-induced organ dysfunction, including circulatory and cardiac dysfunction, hepatic dysfunction, renal dysfunction, etc., contributes to high mortality and long-term disability of sepsis patients. Altered inflammatory response, ROS and reactive aldehyde stress, mitochondrial dysfunction, and programmed cell death pathways (necrosis, apoptosis, and autophagy) have been demonstrated to play crucial roles in septic organ dysfunction. Unfortunately, except for infection control and supportive therapies, no specific therapy exists for sepsis. New specific therapeutic targets are highly warranted. Emerging studies suggested a role of potential therapeutic target of ALDH2, a tetrameric enzyme located in mitochondria to detoxify aldehydes, in septic organ dysfunction. In this article, we will review the presentations and pathophysiology of septic organ dysfunction, as well as summarize and discuss the recent insights regarding ALDH2 in sepsis.

• Authors: Jiaojiao Pang, Yue Zheng, Qi Han, Ying Zhang, Ruru Sun, Jiali Wang, Feng Xu, Yingmei Zhang, Jun Ren, Yuguo Chen
• Journal: Advances in experimental medicine and biology (Adv Exp Med Biol) Vol. 1193 Pg. 175-194 ( 2019) ISSN: 0065-2598 [Print] United States
• PMID: 31368104 (Publication Type: Journal Article, Review)

Chemical References

• ALDH2 protein, human
• Aldehyde Dehydrogenase, Mitochondrial

Topics

• Aldehyde Dehydrogenase, Mitochondrial (genetics)
• Apoptosis
• Autophagy
• Humans
• Mitochondria (enzymology)
• Sepsis (genetics)